Mpox IHR Emergency Committee
The IHR Emergency Committee on the multi-country outbreak of mpox held its first meeting on 23 June 2022. On 23 July 2022, the WHO Director-General determined the event to constitute a Public Health Emergency of International Concern (PHEIC) and issued Temporary Recommendations to States Parties accordingly. On 11 May 2023, the WHO Director-General determined that the event no longer constituted a PHEIC, and issued Temporary Recommendations to States Parties, in accordance with IHR (2005) provisions.
Meetings reports and temporary recommendations
Director-General's statements and opening remarks
Chair
Dr Jean-Marie Okwo-Bele
Public health consultant, Kinshasa, Democratic Republic of the Congo Former director of the vaccines and immunization department, WHO Headquarters, Geneva, Switzerland (Retired)
Vice-chair
Dr Nicola Low
Associate Professor, Epidemiology and Public Health Medicine, Institute of Social and Preventive Medicine, University of Bern
Rapporteur
Dr Inger K. Damon
Director, Division of High Consequence Pathogens and Pathology
Members
Dr Daniel Bausch
Senior Director, Emerging Threats and Global Health Security, FIND, The Global Alliance for Diagnostics, Switzerland
Dr Clarissa Damaso
Associate Professor, Head of Laboratory of Molecular Biology of Viruses
Dr Jake Dunning
Senior Researcher, Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom
Dr Ousmane Faye
Head, Virology Unit, Institut Pasteur de Dakar, Senegal
Dr Rinat Maksyutov
Director General, Federal Budgetary Research Institution
Dr Othoman Mellouk
Lead, Access to Diagnostics and Medicines, International Treatment, Preparedness Coalition, Morocco
Dr Dimie Ogoina
Professor of Medicine and Infectious Diseases, Niger Delta University Head - Infectious Diseases Unit, Niger Delta University Teaching Hospital, Bayelsa, Nigeria
Dr Nittaya Phanuphak
Executive Director, Institute of HIV Research and Innovation, Bangkok, Thailand
Dr. Anne Rimoin
Professor, Epidemiology and Gordon-Levin Endowed Chair in Infectious Diseases and Public Health, Fielding School of Public Health, University of California, Los Angeles, United States of America
Dr Tomoya Saito
Director, Center for Emergency Preparedness and Response National Institute of Infectious Diseases, Japan
Dr Daniel Tarantola
Adjunct Research Professor, Institute on Inequalities in Global Health, Keck School of Medicine, University of Southern California, United States of America Former Director of the Vaccines and Immunization Department, WHO HQ, Geneva, Switzerland (Retired)
Dr Zunyou Wu
Chief Epidemiologist, Chinese Center for Disease Control and Prevention, Director, Division of HIV Prevention, NCAIDS/China CDC, China Adjunct Professor of Epidemiology, University of California, Los Angeles, United States
Advisors
Dr Steve Ahuka
Chief, Department of Virology, National Institute of Biomedical Research, Democratic Republic of the Congo
Dr Vittoria Colizza
Head of Research, INSERM (French National Institute for Health and Medical Research) and Faculty of Medicine, Sorbonne Université, Paris, France
Dr Demetre Daskalakis
Director, Division of HIV/AIDS Prevention, Centres of Disease Control and Prevention, United States of America
Dr Cleiton Euzebio De Lima
Senior Adviser, Communities and Key Populations, UNAIDS headquarters, Geneva, Switzerland
Dr Gregg Gonsalves
Associate Professor, Epidemiology, Yale Institute for Global, Health, Yale School of Public Health, Yale University, United States of America
Prof David L. Heymann
Professor of Infectious Disease Epidemiology, LSHTM, UK; Head, Centre on Global Health Security, Chatham House, London, UK; Former Assistant Director-General for Health Security, WHO HQ, Switzerland (Retired)
Dr Wanda Markotter
Director, Centre for Viral Zoonoses, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, South Africa
Dr Gianfranco Spiteri
Group Lead, Epidemic Intelligence Group, European Centre for Disease Prevention and Control, Sweden
Dr Theresa Tam
Chief Public Health Officer, Public Health Agency of Canada, Canada
Former members
Dr Kathrina Summermatter
Head of the Biosafety Center and Managing Director of the Biosafety Level 3 Laboratory at the Institute for Infectious Diseases at the University of Berne, Switzerland